Lyell Immunopharma News

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%), etc.

Feb 15 04:24

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lang Matthew

Feb 14 09:31

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Hill Stephen J.

Feb 14 09:26

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lee Gary K.

Feb 14 09:26

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Newton Charles W.

Feb 14 09:21

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Seely Lynn

Feb 14 09:21

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.40%)

Feb 14 06:52

Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.7%)

Jan 30 06:37

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Newton Charles W.

Nov 21, 2023 09:55

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lee Gary K.

Nov 21, 2023 09:54

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Seely Lynn

Nov 21, 2023 09:53

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Hill Stephen J.

Nov 21, 2023 09:52

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard

Sep 9, 2023 04:30

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director RIEFLIN WILLIAM JL

Sep 9, 2023 04:27

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director FRIEDMAN CATHY

Sep 9, 2023 04:26

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT

Sep 9, 2023 04:24

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NABEL ELIZABETH G

Sep 9, 2023 04:23

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director BRAWLEY OTIS W

Sep 9, 2023 04:22

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Bishop Hans Edgar

Sep 9, 2023 04:20

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard

Aug 18, 2023 04:23